CCM net profit down 44% on absence of pharma ops
On its prospects, CCM said it is “putting strong effort” to expand its chemicals and polymers divisions, since the de-merger of CCM Duopharma.
PETALING JAYA: Chemical Company of Malaysia 
Bhd’s (CCM) net profit was slashed 44% year-on-year (y-o-y) in the third quarter of financial year 2018, mainly due to the absence of profit from its now-discontinued operations and higher tax expenses.
The chemicals and polymers producer told Bursa Malaysia that its net profit fell to RM4.57mil from RM8.2mil a year earlier.
The absence of profit from CCM’s discontinued pharmaceuticals business, CCM Duopharma Biotech Bhd , dragged down the earnings.
...
The content is a snapshot from Publisher. Refer to the original content for accurate info. Contact us for any changes.
Related Stocks
Comments